Medical Journals

Cerebral Ischemia Combined with Beta-amyloid Impairs Spatial Memory in the Eight-arm Radial Maze Task in Rats.

Authors:
  • Iwasaki Katsunori
  • Egashira Nobuaki
  • Hatip-Al-Khatib Izzettin
  • Akiyoshi Yuki
  • Arai Takashi
  • Takagaki Yuki
  • Watanabe Takuya
  • Mishima Kenichi
  • Fujiwara Michihiro

From: Department of Neuropharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-Ku, Fukuoka 814-0180, Japan. iwasakik@fukuoka-u.ac.jp

Brain research

  • Publish Date: Jun 2006
  • ISSN: 0006-8993
  • Volume: 1097
  • Issue: 1
  • Pages: 216-23
  • Medium: Print
  • Language: English
  • Citation (JAMA): Iwasaki Katsunori, Egashira Nobuaki, Hatip-Al-Khatib Izzettin, et al. Cerebral Ischemia Combined with Beta-amyloid Impairs Spatial Memory in the Eight-arm Radial Maze Task in Rats.. Brain Res. Jun 2006;1097:216-23

Abstract

beta-Amyloid (Abeta), a major component of senile plaques in Alzheimer’s disease, has been implicated in neuronal cell death, a characteristic feature of this condition. In our previous experiments using primary cultures of hippocampal neurons, Abeta treatment induced neuronal cell death, displaying morphological characteristics of apoptosis that was significantly enhanced by hypoxia. Based on these results, we developed a simple in vivo rat model of Alzheimer’s disease using cerebral ischemia, instead of hypoxia, combined with continuous intracerebroventricular administration of Abeta. The combination of cerebral ischemia and Abeta administration, but not either treatment alone, significantly impaired spatial memory in an eight-arm radial maze. A microdialysis study showed that spontaneous release of acetylcholine (ACh) from the dorsal hippocampus had a tendency to decrease in response to Abeta treatment alone or the combination of ischemia and Abeta. High K(+)-evoked increase in ACh release had a tendency to be inhibited by either ischemia or Abeta treatment alone and was significantly inhibited by the combination of both. Moreover, combination of ischemia and Abeta induced apoptosis of pyramidal neurons in the CA1 region of the hippocampus. Donepezil, a drug currently in clinical use for Alzheimer’s disease, improved the impairment of spatial memory induced by cerebral ischemia combined with Abeta. These findings suggest that ischemia is an important factor facilitating the symptoms of Alzheimer’s disease, and this model may be useful for developing new drugs for the treatment of Alzheimer’s disease.

Mesh Headings (Keywords): Amyloid beta-Protein, Animals, Brain Ischemia, Male, Maze Learning, Memory, Rats, Rats, Wistar, Space Perception


Check for Full Text / PubMed Unique Identifier (PMID): 16729978


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.